Cylocide N 1gm (Cytarabine Vials) 1gm

Cylocide N 1gm (Cytarabine) is an antineoplastic agent available in vial form, used in chemotherapy regimens. This 1gm strength formulation is designed for systemic administration. Store at ambient temperature and follow handling guidelines for cytotoxic drugs.

Strength

1gm

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Nippon Shinyaku Co., Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cytarabine is primarily used as part of combination chemotherapy for acute myeloid leukemia (AML) and other hematologic malignancies. It may also be used in maintenance therapy for certain cancers. This medication works by interfering with DNA synthesis in rapidly dividing cells. Patients often ask what Cytarabine is used for in cancer treatment protocols.

Side Effects

Cytarabine may cause bone marrow suppression, leading to reduced blood cell counts. Gastrointestinal effects like nausea or vomiting are common. Fatigue and hair loss may also occur during treatment cycles. These effects vary based on dosage and individual response to therapy.

Precautions & Warnings

Handle Cytarabine with care as it is a cytotoxic agent; use protective equipment during preparation. Avoid exposure during pregnancy and breastfeeding. Regular blood monitoring is recommended to track treatment effects. Keep vials in a secure location away from children.

Avoid Interactions

Cytarabine may interact with other chemotherapy drugs or medications affecting bone marrow function. Alcohol and certain supplements may increase side effects. Live vaccines should be avoided during treatment. Always inform healthcare providers about all medications being taken.

Frequently Asked Questions

Cytarabine is used primarily for acute myeloid leukemia and other hematologic cancers as part of chemotherapy regimens.

Cytarabine is typically given by injection or infusion under medical supervision.

Common effects include nausea, bone marrow suppression, fatigue, and hair loss.

Yes, Cytarabine vials should be stored at ambient temperature as indicated on the packaging.

Cytarabine may harm unborn babies; consult a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.